XASX
PCK
Market cap44mUSD
Jul 09, Last price
0.04AUD
1D
2.78%
1Q
23.33%
Jan 2017
23.33%
IPO
-87.09%
Name
PainChek Ltd
Chart & Performance
P/E
—
P/S
25.51
EPS
—
Div Yield, %
—
Shrs. gr., 5y
11.64%
Rev. gr., 5y
65.46%
Revenues
3m
+37.06%
Net income
-8m
L+9.68%
CFO
-7m
L+12.73%
Earnings
Jul 28, 2025
Profile
PainChek Limited develops and commercializes mobile medical device applications that provides pain assessment for individuals. The company offers PainChek, which uses camera in smartphones and tablets to capture video that is analyzed in real time using facial recognition software to indicate the presence of the pain. It serves patients suffering with dementia. The company was formerly known as ePAT Technologies Ltd and changed its name to PainChek Limited in January 2018. PainChek Limited is based in Sydney, Australia.
Valuation
Title AUD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|
| 2024‑06 | 2023‑06 | 2022‑06 | 2021‑06 | 2020‑06 | 2019‑06 | 2018‑06 | 2017‑06 | 2016‑06 | |
| Income | |||||||||
Revenues | 2,672 37.06% | 1,950 99.22% | |||||||
Cost of revenue | 11,476 | 9,945 | |||||||
Unusual Expense (Income) | |||||||||
NOPBT | (8,804) | (7,996) | |||||||
NOPBT Margin | |||||||||
Operating Taxes | (1,049) | ||||||||
Tax Rate | |||||||||
NOPAT | (8,804) | (6,947) | |||||||
Net income | (8,308) 9.68% | (7,575) 32.41% | |||||||
Dividends | |||||||||
Dividend yield | |||||||||
Proceeds from repurchase of equity | 8,668 | 2,569 | |||||||
BB yield | -22.01% | -7.97% | |||||||
| Debt | |||||||||
Debt current | |||||||||
Long-term debt | |||||||||
Deferred revenue | |||||||||
Other long-term liabilities | |||||||||
Net debt | (3,562) | (2,512) | |||||||
| Cash flow | |||||||||
Cash from operating activities | (7,128) | (6,323) | |||||||
CAPEX | (34) | (14) | |||||||
Cash from investing activities | (34) | (12) | |||||||
Cash from financing activities | 8,209 | 2,696 | |||||||
FCF | (8,810) | (6,944) | |||||||
| Balance | |||||||||
Cash | 3,562 | 2,512 | |||||||
Long term investments | |||||||||
Excess cash | 3,428 | 2,415 | |||||||
Stockholders' equity | 1,290 | 668 | |||||||
Invested Capital | |||||||||
ROIC | |||||||||
ROCE | |||||||||
| EV | |||||||||
Common stock shares outstanding | 1,458,519 | 1,289,989 | |||||||
Price | 0.03 8.00% | 0.03 -10.71% | |||||||
Market cap | 39,380 22.11% | 32,250 2.08% | |||||||
EV | 35,818 | 29,738 | |||||||
EBITDA | (8,778) | (7,979) | |||||||
EV/EBITDA | |||||||||
Interest | |||||||||
Interest/NOPBT | |||||||||